Browse Category by Medication
Health, Medical, Medication

Amicus Therapeutics Take Their Responsibilities Seriously And Follow Their Core Principles

Amicus Therapeutics treats rare diseases with biotechnology. Their interest in genetic diseases has led to numerous treatments including migalastat. Migalastat is a candidate for the treatment of Fabry disease, and is based on the genetic diagnosis of the individual. Another development of Amicus Therapeutics is called SD-101, and it has reached the later stages in its development. This has been designed for the Epidermolysis Bullosa disorder which affects the connective tissues. Amicus Therapeutics strives to help the individuals suffering from rare diseases, and some of their candidates are expected to be the first available on the market.

 

The employees of Amicus Therapeutics joined forces and decided to create a statement that would reflect their beliefs, and values. This provided a reminder of why they work so hard every day, and what they hope to achieve. These beliefs are critical in understanding the strength of the commitment, and depth of passion Reflected by the proud employees of Amicus Therapeutics. They believe fighting to find therapies to help individuals with rare diseases is worth every moment of effort it requires. They strive to ensure their therapies provide the highest quality of help for these individuals (Indeed).

 

Amicus Therapeutics is about the community, individuals affected by serious diseases, and their families. The employees serve with passion, duty, new ideas, and technologies. Their core values represent their dedication to the work they do, their ability to accept new ideas, and the value of taking a smart risk. Amicus Therapeutics is not afraid to ask the really hard questions, and never limit themselves to outdated thinking. When they make a mistake, they gain knowledge, and experience, and continue their forward momentum.

 

Amicus Therapeutics reached for the future with a strong belief in science, strategic partnerships, and their shareholders. They price their medications fairly, make them accessible, and are responsible for their actions. They understand their success in the future is based on honesty, accountability, and teamwork. They make the contribution of every individual count, and communicate with diversity, respect, and a health balance. Although the employees of Amicus Therapeutics have fun, they never shirk their responsibilities.

More at http://weeklyopinion.com/2017/08/amicus-therapeutics-announces-the-launch-of-new-drug/